Mark S. Verratti

Mark S. Verratti

Chief Operating OfficeratMyriad Genetics· In proxies 2021–2025

Pay in FY2025-15% from the year before · Myriad Genetics stock -55.1% the same year

Mark S. Verratti was paid $3.1M in FY2025 (Dec), down 15%. Myriad Genetics stock fell 55.1% that year.

Pay$100 in the stock at the end of FY20 → $31
Pay is from the Summary Compensation Table of each Myriad Genetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Myriad GeneticsPublic company · 5 yr
    • Chief Operating Officer2021 – Present · 5 yrStock in role -64%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?